Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Hematological Indices as Prognostic Markers of Inflammatory Complications and Multiple Organ Dysfunction in Cardiac Surgery Patients.

NCT06476171 is registered in ClinicalTrials.gov with Petrovsky National Research Centre of Surgery as lead sponsor.

NCT NCT06476171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06476171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Hematological Indices as Prognostic Markers of Inflammatory Complications and Multiple Organ Dysfunction in Cardiac Surgery Patients.
Lead sponsor
Petrovsky National Research Centre of Surgery
Phase
Not applicable
Overall status
Recruiting
Start date
June 19, 2023
Completion date
December 30, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple organ dysfunction, pneumonia, sepsis, wound infection